1. 1,25-Dihydroxyvitamin D3 modulates adipogenesis of human adipose-derived mesenchymal stem cells dose-dependently
- Author
-
Saeed Mohammadi, Ali Asghar Farshad, Asal Neshatbini Tehrani, Amin Salehpour, Mehdi Hedayati, and Farzad Shidfar
- Subjects
medicine.medical_specialty ,030309 nutrition & dietetics ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Adipose tissue ,lcsh:TX341-641 ,Calcitriol receptor ,03 medical and health sciences ,chemistry.chemical_compound ,1,25-Dihydroxyvitamin D3 ,Adipocyte ,Fatty acid binding ,Internal medicine ,medicine ,Obesity ,lcsh:RC620-627 ,030304 developmental biology ,0303 health sciences ,Nutrition and Dietetics ,biology ,Chemistry ,Research ,Correction ,lcsh:Nutritional diseases. Deficiency diseases ,Fatty acid synthase ,Endocrinology ,Adipogenesis ,Lipogenesis ,Adipogenic differentiation ,biology.protein ,Mesenchymal stem cells ,lcsh:Nutrition. Foods and food supply ,GLUT4 - Abstract
Purpose 1,25-dihydroxyvitamin D3 may regulate adipogenesis in adipocytes in-vitro, but little is known about possible molecular mechanisms related to the inhibitory effect of 1,25-dihydroxyvitamin D3 on adipogenesis in humans҆ adipose tissue. Methodology In this study, human adipose-derived mesenchymal stem cells (hASCs) were cultured for 14 days in adipogenic differentiation media containing concentrations of 1,25-dihydroxyvitamin D3 (10−10–10−8 M). The extent of adipogenic differentiation in ASCs was assessed by Oil Red O staining and quantitative polymerase chain reaction (PCR) to determine expression levels of key adipogenic markers. Results Our results showed that vitamin D receptor (VDR), as a mediator of most actions of 1,25-dihydroxyvitamin D3, glucose trasporter-4 (GLUT4),and fatty acid binding protein-4 (FABP4) was expressed in vitamin D-treated hASCs. However, the protein level of these markers was lower than the control group. Treatment of human preadipocytes with 1,25-dihydroxyvitamin D3 significantly altered expression of adipogenic markers and triglyceride accumulation in a dose-dependent manner. 1,25-dihydroxyvitamin D3 at concentration of 10−8 M enhanced expression of sterol regulatory element-binding protein-1c (SREBP1c), CCAAT-enhancer-binding protein-β (C/EBPβ), a mitotic clonal expansion, peroxisome proliferator-activated receptor-gamma (PPARγ), fatty acid synthase (FASN), a marker of de novo lipogenesis,and lipoprotein lipase (LPL). Conclusion Our findings revealed that 1,25-dihydroxyvitamin D3 may provoke adipocyte development in critical periods of adipogenesis at concentration of 10−8 M, thereby leading to a greater risk of obesity in adulthood and an augmented risk of obesity-related diseases including diabetes, cardiovascular diseases, and some cancers.
- Published
- 2021